Advertisement
U.S. markets closed

InMed Pharmaceuticals Inc. (INM)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
0.3640+0.0320 (+9.64%)
At close: 04:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Upgrade to begin using 40 years of financial statements and get so much more.
 
As of Date: 3/29/2024
Current
12/31/20239/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
2.21M2.75M2.33M3.08M3.59M3.21M
Enterprise Value
-6.16M-3.70M-6.19M-6.02M-7.30M-5.44M
Trailing P/E
N/A8.32N/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
0.300.270.410.700.730.94
Price/Book (mrq)
0.170.250.190.250.250.29
Enterprise Value/Revenue
-1.12-2.98-6.87-2.61-7.06-11.58
Enterprise Value/EBITDA
0.962.382.5016.493.652.61

Trading Information

Stock Price History

Beta (5Y Monthly) 0.47
52-Week Change 3-66.30%
S&P500 52-Week Change 327.86%
52 Week High 32.0800
52 Week Low 30.2910
50-Day Moving Average 30.3645
200-Day Moving Average 30.6225

Share Statistics

Avg Vol (3 month) 3164.01k
Avg Vol (10 day) 363.42k
Shares Outstanding 56.06M
Implied Shares Outstanding 66.06M
Float 84.84M
% Held by Insiders 11.36%
% Held by Institutions 113.28%
Shares Short (Mar 15, 2024) 456.97k
Short Ratio (Mar 15, 2024) 40.2
Short % of Float (Mar 15, 2024) 40.94%
Short % of Shares Outstanding (Mar 15, 2024) 40.94%
Shares Short (prior month Feb 15, 2024) 4138.25k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 06, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:25
Last Split Date 3Sep 07, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -115.75%
Operating Margin (ttm)-137.47%

Management Effectiveness

Return on Assets (ttm)-27.17%
Return on Equity (ttm)-46.86%

Income Statement

Revenue (ttm)5.49M
Revenue Per Share (ttm)1.22
Quarterly Revenue Growth (yoy)164.00%
Gross Profit (ttm)N/A
EBITDA -6.78M
Net Income Avi to Common (ttm)-6.35M
Diluted EPS (ttm)-0.4200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.58M
Total Cash Per Share (mrq)1.58
Total Debt (mrq)1.17M
Total Debt/Equity (mrq)9.14%
Current Ratio (mrq)7.03
Book Value Per Share (mrq)2.25

Cash Flow Statement

Operating Cash Flow (ttm)-6.34M
Levered Free Cash Flow (ttm)-4.19M